Infants Receiving Very Early Antiretroviral Therapy Have High CD4 Counts in the First Year of Life

Bryan S. Nelson, Camlin Tierney, Deborah Persaud, Jennifer Jao, Mark F. Cotton, Yvonne Bryson, Anne Coletti, Theodore D. Ruel, Stephen A. Spector, Christina Reding, Kira Bacon, Diane Costello, Charlotte Perlowski, Maria Leticia Santos Cruz, Josphat Kosgei, Sai Majji, Dwight E. Yin, Patrick Jean-Philippe, Ellen G. Chadwick

Research output: Contribution to journalArticlepeer-review

Abstract

We followed 54 infants with in utero HIV after initiating very early antiretroviral treatment. At weeks 24 and 48, ≥80% had CD4 ≥1500 cells/mm3 and CD4% ≥25%. Routine Pneumocystis jirovecii pneumonia prophylaxis in the first year of life may not be necessary for all very early treated infants.

Original languageEnglish (US)
Pages (from-to)E744-E747
JournalClinical Infectious Diseases
Volume76
Issue number3
DOIs
StatePublished - Feb 1 2023

Keywords

  • CD4
  • HIV
  • Pneumocystis jirovecii pneumonia
  • cotrimoxazole
  • neonatal

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Infants Receiving Very Early Antiretroviral Therapy Have High CD4 Counts in the First Year of Life'. Together they form a unique fingerprint.

Cite this